SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported)

March 30, 2007

Bioenvision, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-31787

 

13-4025857

(Commission File Number)

 

(I.R.S. Employer Identification No.)

345 Park Avenue, 41st Floor, New York, New York

10154

(Address of Principal Executive Offices)

(Zip Code)

(212) 750-6700

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):

o           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

 


 

Item 9.01

Financial Statements and Exhibits.

 

(d) Exhibits

 

 

Exhibit Number

Description

 

23.1

Consent of J.H. Cohn LLP, Independent Registered Public Accounting Firm

 

23.2

Consent of Deloitte & Touche LLP, Prior Independent Registered Public
Accounting Firm

 

23.3

Consent of Grant Thornton LLP, Prior Independent Registered Public
Accounting Firm

 

 

 

1

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BIOENVISION, INC.

March 30, 2007

By:

                     /s/ David P. Luci                            

 

Name:

David P. Luci

 

Title:

Executive Vice President, General Counsel and Corporate Secretary

 

 

2

 

 

 


 

EXHIBIT INDEX

 

 

23.1

Consent of J.H. Cohn LLP, Independent Registered Public Accounting Firm

23.2

Consent of Deloitte & Touche LLP, Prior Independent Registered Public
Accounting Firm

23.3

Consent of Grant Thornton LLP, Prior Independent Registered Public
Accounting Firm

 

 

 

 

1